Consistent with our result, Sang et al performed an immunohistochemistry assay in 141 cases of LGG and found YAP1 and pSTAT3-S727 co-expression might serve as a reliable prognostic biomarker and therapeutic target for glioma [30]. Here, YAP1 is linked to central nervous system cancer.